Abstract
dc:descriptionThe significant biological/pharmaceutical interest of azaheterocyclic compounds has initiated a vigorous research activity towards the development of methodologies for the efficient synthesis of novel bioactive molecules containing in their structural frameworks diverse azaheterocyclic rings. The endeavor herein falls within this initiative, focusing on the development of several novel derivatives of pyrazoles and isoxazoles, molecules containing the azaheterocyclic ring residue and displaying multidimensional biological activities. Final goal was the development of novel molecules with potent anticancer and/or antiangiogenic activities.In this respect, we designed, synthesized and determined the bioactivities of novel derivatives of: 1)pyrazoles, synthesized via the condensation of 1,3-diketones with hydrazines,2)isoxazoles, prepared by the condensation of 1,3-diketones with hydroxylamines,3)pyrazole[1,5a]pyrimidines, analogues of the bioactive molecule dorsomorphinSubsequently, the biological activities of the novel compounds, along with their chemical structures were utilized for the development and validation of an in silico model, used for the design, synthesis and bioactivity determination of several additional target molecules with anticipated anticancer activities. The structures of all novel molecules were elucidated using NMR spectroscopy (1H, 13C, 2D, etc) experiments, while their anticancer activity was evaluated through several in vitro assays determing the inhibition of endothelial and cancer cells proliferation. Finally, their antiangiogenic activity was evaluated by in vitro assays of the inhibition of cell tubes formation and cell migration.In particular, during the implementation of this thesis the following activities were performed: a) Synthesis of 59 novel molecules, which had been set as the target compounds. Amongst them, 23 are pyrazole derivatives, 20 isoxazole and 16 are analogues of dorsomorphin.b) Development, validation and utilization of novel in silico model for the discovery of potentially bioactive molecules. The model was used for the design and synthesis of novel derivatives of isoxazole.c) Determination of the anticancer activities of all novel molecules synthesized herein. The results pointed out the pyrazolic compound Π-9 as the most active against the MCF-7 cells, displaying IC50 = 1.5 ± 0.4 µM, while isoxazoles Π-35 and Π-38 (developed using the classification model) exhibited the best antiproliferative activities, with IC50 values below 1μM against most cell lines tested. d) Synthesis of novel dorsomorphine analogues, with compounds Π-46, Π-50 and Π-57 showing the most potent antiproliferative activity with IC50 values below 10 μM against most cancer cell lines.e) Evaluation of all novel compounds as inhibitors of angiogenesis through the assessment of their tube formation inhibition potencies, highlighting as the most actives the derivatives of pyrazole Π-12 and isoxazole Π-35 and Π-38. In addition, the antiangiogenic mechanism of compounds Π-22, Π-23, Π-36 and Π-38 was found to proceed through the deactivation of VEGF pathway.f) It was found that the novel pyrazolo[1,5a]pyrimidine derivative Π-46 exhibits significant antiviral activity against a variety of herpes viruses.
Degree
thesis:*- Grantor dc:publisher
- Agricultural University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzanetou, Evangelia
- Τζανέτου, Ευαγγελία
Subjects
dc:subject × 27- Σύνθεση βιοδραστικών μορίων
- Μικροκυματική σύνθεση
- Πυραζόλια
- Ινδαζόλια
- Ισοξαζόλια
- Πυραζολοπυριδίνες
- Ντορσομορφίνη
- Κυτταροστατική δράση
- Αναστολή της αγγειογένεσης
- Αντικαρκινική δράση
- Σχηματισμός μικροσωληνίσκων
- Μοντέλο πρόβλεψης βιοδραστικότητας
- Synthesis of bioactive compounds
- Pyrazoles
- Indazoles
- Isoxazoles
- Pyrazolopyrimidines
- Dorsomoprhine
- Antiproliferative activity
- Inhibition of angiogenesis
- Anticancer activity
- Tube formation
- Bioactivity prediction model
- Φυσικές Επιστήμες
- Χημεία
- Natural Sciences
- Chemical Sciences
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40603